Display options
Cite
Lamplot JD, Denduluri S, Qin J, et al. The Current and Future Therapies for Human Osteosarcoma. Curr Cancer Ther Rev. 2013;9(1):55-77doi: 10.2174/1573394711309010006.
Lamplot, J. D., Denduluri, S., Qin, J., Li, R., Liu, X., Zhang, H., Chen, X., Wang, N., Pratt, A., Shui, W., Luo, X., Nan, G., Deng, Z. L., Luo, J., Haydon, R. C., He, T. C., & Luu, H. H. (2013). The Current and Future Therapies for Human Osteosarcoma. Current cancer therapy reviews, 9(1), 55-77. https://doi.org/10.2174/1573394711309010006
Lamplot, Joseph D, et al. "The Current and Future Therapies for Human Osteosarcoma." Current cancer therapy reviews vol. 9,1 (2013): 55-77. doi: https://doi.org/10.2174/1573394711309010006
Lamplot JD, Denduluri S, Qin J, Li R, Liu X, Zhang H, Chen X, Wang N, Pratt A, Shui W, Luo X, Nan G, Deng ZL, Luo J, Haydon RC, He TC, Luu HH. The Current and Future Therapies for Human Osteosarcoma. Curr Cancer Ther Rev. 2013 Feb;9(1):55-77. doi: 10.2174/1573394711309010006. PMID: 26834515; PMCID: PMC4730918.
Copy Download .nbib Format: NLM
Share it on

Curr Cancer Ther Rev. 2013 Feb;9(1):55-77. doi: 10.2174/1573394711309010006.

The Current and Future Therapies for Human Osteosarcoma.

Current cancer therapy reviews

Joseph D Lamplot, Sahitya Denduluri, Jiaqiang Qin, Ruidong Li, Xing Liu, Hongyu Zhang, Xiang Chen, Ning Wang, Abdullah Pratt, Wei Shui, Xiaoji Luo, Guoxin Nan, Zhong-Liang Deng, Jinyong Luo, Rex C Haydon, Tong-Chuan He, Hue H Luu

Affiliations

  1. Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, IL 60637, USA.
  2. Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, IL 60637, USA; Stem Cell Biology and Therapy Laboratory of the Key Laboratory for Pediatrics co-designated by Chinese Ministry of Education, The Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
  3. Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, IL 60637, USA; The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, China.
  4. Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, IL 60637, USA; Department of Orthopaedic Surgery, The Affiliated Tangdu Hospital of the Fourth Military Medical University, Xi'an 710032, China.
  5. Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, IL 60637, USA; Department of Oncology, the Affiliated Southwest Hospital of the Third Military Medical University, Chongqing 400038, China.
  6. Molecular Oncology Laboratory, Department of Orthopaedic Surgery, The University of Chicago Medical Center, Chicago, IL 60637, USA; Stem Cell Biology and Therapy Laboratory of the Key Laboratory for Pediatrics co-designated by Chinese Ministry of Education, The Children's Hospital of Chongqing Medical University, Chongqing 400014, China; The Affiliated Hospitals and the Key Laboratory of Diagnostic Medicine designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, China.

PMID: 26834515 PMCID: PMC4730918 DOI: 10.2174/1573394711309010006

Abstract

Osteosarcoma (OS) is the most common non-hematologic malignant tumor of bone in adults and children. As sarcomas are more common in adolescents and young adults than most other forms of cancer, there are a significant number of years of life lost secondary to these malignancies. OS is associated with a poor prognosis secondary to a high grade at presentation, resistance to chemotherapy and a propensity to metastasize to the lungs. Current OS management involves both chemotherapy and surgery. The incorporation of cytotoxic chemotherapy into therapeutic regimens escalated cure rates from <20% to current levels of 65-75%. Furthermore, limb-salvage surgery is now offered to the majority of OS patients. Despite advances in chemotherapy and surgical techniques over the past three decades, there has been stagnation in patient survival outcome improvement, especially in patients with metastatic OS. Thus, there is a critical need to identify novel and directed therapy for OS. Several Phase I trials for sarcoma therapies currently ongoing or recently completed have shown objective responses in OS. Novel drug delivery mechanisms are currently under phase II and III clinical trials. Furthermore, there is an abundance of preclinical research which holds great promise in the development of future OS-directed therapeutics. Our continuously improving knowledge of the molecular and cell-signaling pathways involved in OS will translate into more effective therapies for OS and ultimately improved patient survival. The present review will provide an overview of current therapies, ongoing clinical trials and therapeutic targets under investigation for OS.

Keywords: BMP; Bisphosphonates; IGF; IGFBP5; OS99; limb-salvage; osteosarcoma

References

  1. Cancer Treat Rep. 1978 Feb;62(2):213-6 - PubMed
  2. J Bone Miner Res. 1995 Feb;10(2):178-86 - PubMed
  3. J Clin Oncol. 1994 Dec;12(12):2614-20 - PubMed
  4. J Clin Oncol. 2002 Jan 1;20(1):189-96 - PubMed
  5. J Clin Oncol. 2011 Dec 1;29(34):4534-40 - PubMed
  6. Cancer Treat Rev. 2006 Oct;32(6):423-36 - PubMed
  7. PPAR Res. 2010;2010:956427 - PubMed
  8. J Biol Chem. 2003 Mar 14;278(11):8869-72 - PubMed
  9. Pediatr Blood Cancer. 2008 Jun;50(6):1176-80 - PubMed
  10. Cancer Treat Rep. 1978 Feb;62(2):239-45 - PubMed
  11. Cancer. 1975 Mar;35(3):622-30 - PubMed
  12. Cancer Invest. 2001;19(3):292-315 - PubMed
  13. Curr Cancer Drug Targets. 2004 Dec;4(8):653-71 - PubMed
  14. Eur J Pharmacol. 2007 May 7;562(1-2):28-33 - PubMed
  15. J Clin Oncol. 2011 Dec 1;29(34):4541-7 - PubMed
  16. Nature. 1992 Jul 2;358(6381):80-3 - PubMed
  17. Cancer. 1969 May;23(5):1239-42 - PubMed
  18. Cancer Lett. 2007 Jun 8;250(2):194-205 - PubMed
  19. J Bone Joint Surg Am. 2003 Aug;85-A(8):1544-52 - PubMed
  20. Semin Cancer Biol. 1998;8(5):345-57 - PubMed
  21. J Bone Joint Surg Br. 2008 Jun;90(6):786-94 - PubMed
  22. Anticancer Res. 2008 Jul-Aug;28(4B):2147-54 - PubMed
  23. J Clin Oncol. 1998 Aug;16(8):2659-71 - PubMed
  24. Cancer. 1975 Sep;36(3):946-9 - PubMed
  25. Curr Opin Oncol. 2011 Jul;23(4):352-60 - PubMed
  26. Clin Cancer Res. 2010 Apr 15;16(8):2235-45 - PubMed
  27. J Pediatr. 1997 May;130(5):828-31 - PubMed
  28. Tumori. 2004 Jul-Aug;90(4):399-404 - PubMed
  29. Clin Orthop Relat Res. 1999 Jan;(358):120-7 - PubMed
  30. Clin Cancer Res. 2002 May;8(5):1288-94 - PubMed
  31. Cancer Genet Cytogenet. 2003 Aug;145(1):1-30 - PubMed
  32. J Clin Oncol. 2005 Mar 20;23(9):2004-11 - PubMed
  33. J Surg Oncol. 1999 Feb;70(2):109-15 - PubMed
  34. Blood. 1998 Jan 1;91(1):222-30 - PubMed
  35. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4503-10 - PubMed
  36. J Bone Joint Surg Am. 1995 Aug;77(8):1154-65 - PubMed
  37. Ann Pharmacother. 1994 Sep;28(9):1063-72 - PubMed
  38. Med Pediatr Oncol. 1978;4(3):221-9 - PubMed
  39. Cancer. 2011 Jun 15;117(12):2770-8 - PubMed
  40. Int J Oncol. 2009 Feb;34(2):551-61 - PubMed
  41. Nucleic Acids Res. 1998 Aug 1;26(15):3453-9 - PubMed
  42. Oncol Res. 1995;7(5):253-7 - PubMed
  43. Am Fam Physician. 2002 Mar 15;65(6):1123-32 - PubMed
  44. Med Sci Monit. 2011 Aug;17(8):RA177-190 - PubMed
  45. Oncogene. 1999 May 13;18(19):3004-16 - PubMed
  46. J Biol Chem. 2002 Nov 1;277(44):41701-5 - PubMed
  47. Rev Endocr Metab Disord. 2001 Jan;2(1):81-94 - PubMed
  48. Science. 1965 Nov 12;150(3698):893-9 - PubMed
  49. Cancer Res. 1997 Sep 15;57(18):3890-4 - PubMed
  50. Cancer. 2011 Apr 15;117(8):1736-44 - PubMed
  51. Cell. 1995 Dec 15;83(6):993-1000 - PubMed
  52. Tumori. 2003 May-Jun;89(3):263-8 - PubMed
  53. Arch Dis Child. 2000 Aug;83(2):143-5 - PubMed
  54. Oncogene. 2011 Sep 15;30(37):3907-17 - PubMed
  55. J Clin Oncol. 2003 Apr 15;21(8):1574-80 - PubMed
  56. Cancer. 1996 Jan 1;77(1):71-8 - PubMed
  57. Cancer Treat Res. 2009;152:239-62 - PubMed
  58. Am J Clin Oncol. 1994 Jun;17(3):273-6 - PubMed
  59. J Chemother. 2001 Feb;13(1):93-9 - PubMed
  60. J Neurooncol. 1988;6(1):47-52 - PubMed
  61. Acta Orthop Scand. 2002 Jan;73(1):85-8 - PubMed
  62. Mol Cancer Ther. 2005 Apr;4(4):625-31 - PubMed
  63. Cancer Chemother Pharmacol. 1978;1(1):61-4 - PubMed
  64. Mayo Clin Proc. 2003 Feb;78(2):147-55 - PubMed
  65. J Clin Oncol. 2001 Jan 1;19(1):171-82 - PubMed
  66. Clin Orthop Relat Res. 2000 Apr;(373):39-50 - PubMed
  67. Natl Cancer Inst Monogr. 1981 Apr;(56):201-6 - PubMed
  68. Cancer. 2009 Nov 15;115(22):5339-48 - PubMed
  69. Clin Orthop Relat Res. 1991 Sep;(270):8-14 - PubMed
  70. J Clin Oncol. 2002 Feb 1;20(3):776-90 - PubMed
  71. Radiology. 1990 Feb;174(2):517-26 - PubMed
  72. J Bone Joint Surg Br. 2009 Oct;91(10 ):1366-72 - PubMed
  73. Anticancer Res. 2000 Jan-Feb;20(1B):485-91 - PubMed
  74. Pediatrics. 1979 May;63(5):741-6 - PubMed
  75. Am J Med Genet. 2002 Oct 15;112(3):266-78 - PubMed
  76. Cancer. 1973 Jun;31(6):1367-73 - PubMed
  77. J Bone Joint Surg Am. 1976 Jul;58(5):629-33 - PubMed
  78. J Natl Med Assoc. 2007 Jul;99(7):785-94 - PubMed
  79. Med Pediatr Oncol. 2002 Jul;39(1):44-6 - PubMed
  80. Pharmacol Ther. 1997;73(1):51-65 - PubMed
  81. Pediatrics. 2008 Mar;121(3):e705-13 - PubMed
  82. Cancer Gene Ther. 2007 Jul;14(7):616-26 - PubMed
  83. Anticancer Res. 2011 Nov;31(11):3953-7 - PubMed
  84. J Clin Oncol. 2008 Jan 20;26(3):399-405 - PubMed
  85. Lancet. 1997 Sep 27;350(9082):911-7 - PubMed
  86. Curr Cancer Drug Targets. 2006 Mar;6(2):123-33 - PubMed
  87. Br J Haematol. 1997 Sep;98(3):665-72 - PubMed
  88. Cancer Res. 2005 Mar 15;65(6):2406-11 - PubMed
  89. J Bone Joint Surg Am. 1994 Mar;76(3):366-78 - PubMed
  90. Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1621-7 - PubMed
  91. Mol Med Today. 2000 Jun;6(6):252-3 - PubMed
  92. Science. 1987 Jan 9;235(4785):177-82 - PubMed
  93. Cell Immunol. 2007 Oct;249(2):63-72 - PubMed
  94. Front Biosci. 2008 Jan 01;13:2001-21 - PubMed
  95. Cancer. 1971 Oct;28(4):844-50 - PubMed
  96. Nat Rev Cancer. 2003 Nov;3(11):859-68 - PubMed
  97. Diagn Mol Pathol. 2001 Mar;10(1):9-14 - PubMed
  98. Cancer. 1997 Dec 15;80(12):2230-9 - PubMed
  99. N Engl J Med. 2005 Oct 20;353(16):1673-84 - PubMed
  100. AJR Am J Roentgenol. 1985 Jan;144(1):95-9 - PubMed
  101. Ann Oncol. 1991 Jul;2(7):489-94 - PubMed
  102. Expert Opin Biol Ther. 2003 Apr;3(2):263-76 - PubMed
  103. JAMA. 1972 Sep 4;221(10):1132-8 - PubMed
  104. Clin Anat. 2004 May;17(4):345-53 - PubMed
  105. Br J Cancer. 1992 Feb;65(2):208-14 - PubMed
  106. J Clin Pharmacol. 1996 Jan;36(1):55-63 - PubMed
  107. Pediatr Blood Cancer. 2004 Jan;42(1):59-63 - PubMed
  108. Cancer. 1990 Feb 15;65(4):861-5 - PubMed
  109. J Pediatr Hematol Oncol. 2008 Dec;30(12):908-12 - PubMed
  110. Eur J Cancer. 2003 Sep;39(14):2050-7 - PubMed
  111. Am J Vet Res. 2005 May;66(5):885-91 - PubMed
  112. Eur J Cancer. 1997 Jul;33(8):1202-8 - PubMed
  113. Pediatr Blood Cancer. 2008 Mar;50(3):581-7 - PubMed
  114. Mol Pharmacol. 2007 Jan;71(1):333-43 - PubMed
  115. J Biol Chem. 2001 Feb 16;276(7):4812-8 - PubMed
  116. Cell. 1997 Feb 7;88(3):323-31 - PubMed
  117. Genes Dev. 2000 Mar 15;14(6):627-44 - PubMed
  118. J Clin Oncol. 2005 Dec 1;23(34):8845-52 - PubMed
  119. Curr Med Chem. 2003 Feb;10(3):257-66 - PubMed
  120. Int J Oncol. 2007 Aug;31(2):285-91 - PubMed
  121. J Orthop Res. 2006 Jun;24(6):1145-52 - PubMed
  122. Cancer Treat Rep. 1978 Feb;62(2):265-9 - PubMed
  123. J Clin Oncol. 2010 Dec 10;28(35):5174-81 - PubMed
  124. Am J Med Genet. 2001 Jul 22;102(1):11-7 - PubMed
  125. Endocrinology. 2007 Jun;148(6):2630-4 - PubMed
  126. J Clin Oncol. 2012 Jul 10;30(20):2545-51 - PubMed
  127. J Clin Oncol. 2010 Nov 20;28(33):4985-95 - PubMed
  128. J Clin Oncol. 1997 Jan;15(1):76-84 - PubMed
  129. J Orthop Res. 2006 Jun;24(6):1138-44 - PubMed
  130. J Biol Chem. 2004 Dec 31;279(53):55958-68 - PubMed
  131. Oncology. 1998 Nov-Dec;55(6):556-63 - PubMed
  132. Blood. 2001 Jan 15;97(2):339-45 - PubMed
  133. Clin Orthop Relat Res. 2010 Nov;468(11):2854-9 - PubMed
  134. Cancer Clin Trials. 1978 Summer;1(2):107-11 - PubMed
  135. J Immunother Emphasis Tumor Immunol. 1995 Apr;17 (3):181-93 - PubMed
  136. Cancer. 1975 Nov;36(5):1598-602 - PubMed
  137. J Craniofac Surg. 2003 Sep;14(5):680-6 - PubMed
  138. Clin Orthop Relat Res. 2003 Oct;(415):52-8 - PubMed
  139. Annu Rev Cell Dev Biol. 2004;20:781-810 - PubMed
  140. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3539-43 - PubMed
  141. Clin Orthop Relat Res. 1980 Nov-Dec;(153):106-20 - PubMed
  142. J Pediatr Surg. 2004 Mar;39(3):418-23; discussion 418-23 - PubMed
  143. Cancer. 2004 May 1;100(9):1928-35 - PubMed
  144. Cancer Res. 2005 Mar 1;65(5):1748-54 - PubMed
  145. Cancer Treat Rev. 1993 Jan;19(1):57-77 - PubMed
  146. Clin Cancer Res. 2010 Aug 1;16(15):4024-30 - PubMed
  147. Science. 1988 Dec 16;242(4885):1528-34 - PubMed
  148. BMC Cancer. 2010 Mar 12;10:96 - PubMed
  149. Pediatr Blood Cancer. 2004 May;42(5):410-5 - PubMed
  150. Cancer Treat Rep. 1985 Jan;69(1):115-7 - PubMed
  151. Eur J Cancer. 2005 Jun;41(9):1349-61 - PubMed
  152. J Bone Joint Surg Am. 1986 Dec;68(9):1331-7 - PubMed
  153. Blood. 1998 Dec 15;92(12):4491-508 - PubMed
  154. J Clin Oncol. 1988 Feb;6(2):329-37 - PubMed
  155. Eur J Surg Oncol. 2012 Dec;38(12):1171-7 - PubMed
  156. J Am Acad Orthop Surg. 2003 Jan-Feb;11(1):25-37 - PubMed
  157. J Surg Res. 2003 May 1;111(1):45-52 - PubMed
  158. Hematol Oncol Clin North Am. 1995 Aug;9(4):927-38 - PubMed
  159. Oncogene. 1994 Jul;9(7):1829-38 - PubMed
  160. Cancer. 1976 Jan;37(1):1-11 - PubMed
  161. Int J Cancer. 2004 Mar;109(1):106-11 - PubMed
  162. J Pediatr Surg. 2006 Jan;41(1):194-9 - PubMed
  163. Clin Orthop Relat Res. 2009 Nov;467(11):2792-9 - PubMed
  164. Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3263-70 - PubMed
  165. Arch Phys Med Rehabil. 1999 Jun;80(6):615-8 - PubMed
  166. Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1311-7 - PubMed
  167. Cancer. 1989 Jan 1;63(1):63-7 - PubMed
  168. Cancer Treat Res. 2009;152:147-64 - PubMed
  169. Curr Opin Genet Dev. 1997 Feb;7(1):46-51 - PubMed
  170. Cancer. 1987 May 1;59(9):1577-81 - PubMed
  171. J Clin Oncol. 2012 Jan 1;30(1):78-84 - PubMed
  172. Med Pediatr Oncol. 1998 Feb;30(2):117-21 - PubMed
  173. Acta Orthop Scand Suppl. 1997 Feb;273:68-73 - PubMed
  174. Breast Cancer Res. 2002;4(1):18-23 - PubMed
  175. Drugs Today (Barc). 2010 May;46(5):327-37 - PubMed
  176. Cancer Res. 2000 Jun 1;60(11):2949-54 - PubMed
  177. Bone Marrow Transplant. 2001 May;27(9):933-7 - PubMed
  178. Cancer Res. 2009 Oct 1;69(19):7662-71 - PubMed
  179. Cancer. 2005 Dec 1;104(11):2522-9 - PubMed
  180. Semin Oncol. 2011 Oct;38 Suppl 3:S19-29 - PubMed
  181. J Bone Joint Surg Am. 1967 Jan;49(1):101-10 - PubMed
  182. Arch Surg. 1992 Sep;127(9):1065-70; discussion 1070-1 - PubMed
  183. J Clin Oncol. 2003 May 15;21(10):2011-8 - PubMed
  184. J Bone Joint Surg Br. 1994 Jan;76(1):127-32 - PubMed
  185. Cancer Chemother Pharmacol. 2008 Jun;62(1):111-6 - PubMed
  186. Cancer Cell. 2002 Apr;1(3):213-5 - PubMed
  187. Endocrinology. 1997 Dec;138(12):5427-33 - PubMed
  188. J Clin Oncol. 1998 Jul;16(7):2452-8 - PubMed
  189. J Clin Oncol. 1999 Oct;17(10):3260-9 - PubMed
  190. Annu Rev Biochem. 1998;67:753-91 - PubMed
  191. Curr Oncol Rep. 2006 Jul;8(4):310-5 - PubMed
  192. Clin Cancer Res. 1999 Sep;5(9):2316-23 - PubMed
  193. J Vet Med Sci. 1999 Jun;61(6):649-56 - PubMed
  194. J Clin Oncol. 2003 Feb 15;21(4):710-5 - PubMed
  195. Eur J Cancer. 2001 May;37(7):870-7 - PubMed
  196. Mol Cell Endocrinol. 2008 Jul 16;289(1-2):38-48 - PubMed
  197. Acta Paediatr. 2000 Feb;89(2):188-93 - PubMed
  198. Clin Orthop Relat Res. 2007 Jan;454:237-46 - PubMed
  199. Cancer Biother Radiopharm. 1999 Apr;14 (2):121-8 - PubMed
  200. Nat Rev Drug Discov. 2004 May;3(5):391-400 - PubMed
  201. Cancer Res. 2005 Sep 15;65(18):8142-50 - PubMed
  202. Int J Cancer. 2002 Dec 1;102(4):338-42 - PubMed
  203. J Clin Oncol. 1992 Aug;10 (8):1310-6 - PubMed
  204. Cancer Res. 1970 Oct;30(10):2572-82 - PubMed
  205. J Cell Biochem. 2004 Dec 15;93(6):1210-30 - PubMed
  206. Natl Cancer Inst Monogr. 1981 Apr;(56):227-31 - PubMed
  207. Mol Ther. 2009 Sep;17(9):1651-7 - PubMed
  208. J Cell Biochem. 1994 Jul;55(3):321-7 - PubMed
  209. Cancer Detect Prev. 1999;23 (2):129-36 - PubMed
  210. Cancer. 1973 Jul;32(1):1-8 - PubMed
  211. J Mammary Gland Biol Neoplasia. 2008 Dec;13(4):471-83 - PubMed
  212. Cleve Clin J Med. 2010 Mar;77 Suppl 1:S23-6 - PubMed
  213. Mol Cancer Ther. 2009 May;8(5):1095-105 - PubMed
  214. Cancer. 2006 Jan 15;106(2):403-12 - PubMed
  215. Clin Cancer Res. 2005 Jul 1;11(13):4666-73 - PubMed
  216. Cancer. 2005 Nov 15;104(10):2214-21 - PubMed
  217. Growth Horm IGF Res. 2007 Jun;17(3):179-85 - PubMed
  218. Cancer. 2004 Apr 15;100(8):1724-33 - PubMed
  219. Oncol Rep. 2002 Jul-Aug;9(4):823-7 - PubMed
  220. J Exp Clin Cancer Res. 2007 Dec;26(4):571-4 - PubMed
  221. Cancer Immunol Immunother. 1994 Jan;38(1):16-22 - PubMed
  222. AJR Am J Roentgenol. 1982 Dec;139(6):1065-9 - PubMed
  223. J Clin Oncol. 1999 Sep;17(9):2781-8 - PubMed
  224. Curr Gene Ther. 2005 Apr;5(2):167-79 - PubMed
  225. Future Oncol. 2006 Jun;2(3):333-43 - PubMed
  226. Blood. 1997 Nov 1;90(9):3245-87 - PubMed
  227. DNA Cell Biol. 2007 Jan;26(1):1-18 - PubMed
  228. Clin Exp Metastasis. 2003;20(6):525-9 - PubMed
  229. Am J Clin Oncol. 1995 Apr;18(2):93-9 - PubMed
  230. J Clin Oncol. 1993 Mar;11(3):449-53 - PubMed
  231. Klin Padiatr. 2001 Jan-Feb;213(1):30-4 - PubMed
  232. Am J Vet Res. 2000 Jan;61(1):69-73 - PubMed
  233. J Cell Mol Med. 2008 Jun;12(3):928-41 - PubMed
  234. Br J Cancer. 2000 Apr;82(8):1459-68 - PubMed
  235. In Vitro Cell Dev Biol Anim. 2004 Mar-Apr;40(3-4):113-7 - PubMed
  236. Cancer. 2011 Oct 1;117(19):4522-30 - PubMed
  237. Gene Ther. 2004 Sep;11(17):1312-20 - PubMed
  238. Br J Cancer. 2007 Jan 29;96(2):255-61 - PubMed
  239. Cancer. 1997 Jan 15;79(2):411-5 - PubMed
  240. Curr Treat Options Oncol. 2009 Apr;10(1-2):82-93 - PubMed
  241. Clin Orthop Relat Res. 1986 Mar;(204):9-24 - PubMed
  242. Pediatr Blood Cancer. 2004 Dec;43(7):729-36 - PubMed
  243. Hum Pathol. 2001 Apr;32(4):410-6 - PubMed
  244. J Pediatr Hematol Oncol. 2005 Nov;27(11):611-5 - PubMed
  245. Pediatr Blood Cancer. 2008 Jun;50(6):1190-7 - PubMed
  246. J Pediatr Orthop B. 2007 Jul;16(4):269-72 - PubMed
  247. Mol Cancer Ther. 2008 Nov;7(11):3461-9 - PubMed
  248. J Surg Oncol. 2007 Aug 1;96(2):118-23 - PubMed
  249. N Engl J Med. 2001 Mar 15;344(11):783-92 - PubMed
  250. J Clin Oncol. 2006 Mar 1;24(7):1161-8 - PubMed
  251. Clin Orthop Relat Res. 1991 Sep;(270):271-7 - PubMed
  252. Cancer. 1983 Feb 1;51(3):402-7 - PubMed
  253. Cancer Res. 1989 Feb 1;49(3):742-4 - PubMed
  254. Cancer Res. 2005 May 1;65(9):3868-76 - PubMed
  255. Nature. 2001 Nov 1;414(6859):105-11 - PubMed
  256. Cancer. 1997 Apr 15;79(8):1541-7 - PubMed
  257. Cancer Res. 1991 Sep 1;51(17):4575-80 - PubMed
  258. J Immunother Emphasis Tumor Immunol. 1993 Nov;14 (4):286-92 - PubMed
  259. Cancer. 1996 Nov 15;78(10):2136-45 - PubMed
  260. Clin Orthop Relat Res. 2008 Aug;466(8):1856-62 - PubMed
  261. J Pharmacol Exp Ther. 2011 Jun;337(3):644-54 - PubMed
  262. J Cell Biol. 1993 Aug;122(3):685-701 - PubMed
  263. Ann Oncol. 2008 Apr;19(4):807-13 - PubMed
  264. J Chemother. 1990 Apr;2(2):127-35 - PubMed
  265. Acta Orthop Scand. 2004 Aug;75(4):487-91 - PubMed
  266. Pediatr Blood Cancer. 2008 Apr;50(4):799-805 - PubMed
  267. EMBO J. 2000 Apr 17;19(8):1745-54 - PubMed
  268. Clin Orthop Relat Res. 1991 Mar;(264):156-68 - PubMed
  269. Bone. 2005 Jul;37(1):74-86 - PubMed
  270. J Natl Cancer Inst. 1989 Jun 21;81(12 ):935-8 - PubMed
  271. Lab Invest. 2007 Feb;87(2):97-103 - PubMed
  272. Nature. 2005 Apr 14;434(7035):843-50 - PubMed
  273. Cancer. 2006 Jul 1;107(1):83-9 - PubMed
  274. J Leukoc Biol. 1999 Jan;65(1):102-8 - PubMed
  275. Cancer J. 2005 Jul-Aug;11(4):294-305 - PubMed
  276. J Clin Oncol. 2009 Dec 1;27(34):5800-7 - PubMed
  277. Expert Rev Anticancer Ther. 2010 Aug;10(8):1313-25 - PubMed
  278. J Clin Oncol. 1987 Jan;5(1):21-6 - PubMed
  279. J Clin Oncol. 1992 Oct;10(10):1579-91 - PubMed
  280. Med Pediatr Oncol. 1978;4(2):127-32 - PubMed
  281. J Clin Oncol. 2000 Dec 15;18(24):4016-27 - PubMed
  282. J Clin Oncol. 2010 Jun 10;28(17):2839-46 - PubMed
  283. J Dent Res. 2005 Apr;84(4):329-34 - PubMed
  284. J Orthop Res. 1993 Jul;11(4):556-63 - PubMed
  285. Bone. 2003 Aug;33(2):216-28 - PubMed
  286. Cancer Lett. 2006 Jul 8;238(1):111-8 - PubMed
  287. Clin Orthop Relat Res. 2006 Dec;453:314-7 - PubMed
  288. J Clin Oncol. 2012 May 20;30(15):1849-56 - PubMed
  289. Eur J Cancer. 2006 Sep;42(13):2124-35 - PubMed
  290. Oncogene. 1999 May 13;18(19):2916-24 - PubMed
  291. Cancer Res. 2003 Aug 15;63(16):5073-83 - PubMed
  292. Sarcoma. 2011;2011:325238 - PubMed
  293. Am J Pathol. 1996 Oct;149(4):1209-19 - PubMed
  294. Cancer. 2005 Sep 1;104(5):1100-9 - PubMed
  295. Cancer. 2003 Dec 1;98(11):2447-56 - PubMed
  296. J Clin Oncol. 2003 Jan 15;21(2):334-41 - PubMed
  297. Clin Orthop Relat Res. 2003 Oct;(415):72-81 - PubMed
  298. Br J Cancer. 2001 Apr 6;84(7):951-8 - PubMed
  299. Cancer Treat Res. 1993;62:101-7 - PubMed
  300. Genes Dev. 1998 Apr 15;12(8):1121-33 - PubMed
  301. J Cancer Res Clin Oncol. 2008 Mar;134(3):281-97 - PubMed
  302. J Clin Oncol. 1994 Sep;12(9):1849-58 - PubMed
  303. Cancer. 2006 Mar 1;106(5):1154-61 - PubMed
  304. Cancer Treat Res. 2009;152:421-36 - PubMed
  305. Oncologist. 2004;9(4):422-41 - PubMed
  306. Cell. 2006 Nov 3;127(3):469-80 - PubMed
  307. Semin Cancer Biol. 1993 Feb;4(1):19-26 - PubMed
  308. J Natl Cancer Inst. 1991 Oct 16;83(20):1460-70 - PubMed
  309. J Clin Invest. 2002 Nov;110(9):1293-9 - PubMed
  310. Cancer. 2011 Apr 15;117(8):1731-5 - PubMed
  311. N Engl J Med. 2010 May 13;362(19):1761-71 - PubMed
  312. J Cell Biochem. 1996 Oct;63(1):37-50 - PubMed
  313. Cancer. 1999 Oct 15;86(8):1602-8 - PubMed
  314. Lab Invest. 2008 Dec;88(12):1264-77 - PubMed
  315. Ann Oncol. 2001 Aug;12(8):1145-50 - PubMed
  316. J Surg Oncol. 1998 Sep;69(1):21-7 - PubMed
  317. Cell. 2002 Apr 5;109(1):113-24 - PubMed
  318. J Mol Diagn. 2001 Nov;3(4):171-7 - PubMed
  319. Prosthet Orthot Int. 2010 Dec;34(4):362-77 - PubMed
  320. Nat Clin Pract Oncol. 2009 Feb;6(2):93-104 - PubMed
  321. Biomed Pharmacother. 1988;42(4):257-62 - PubMed
  322. J Bone Joint Surg Br. 2002 Jan;84(1):88-92 - PubMed
  323. J Orthop Res. 2007 May;25(5):665-77 - PubMed
  324. Cancer. 1987 Jan 15;59(2):374-9 - PubMed
  325. Clin Orthop Relat Res. 1991 Sep;(270):140-8 - PubMed
  326. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2125-31 - PubMed
  327. Rev Recent Clin Trials. 2008 Sep;3(3):228-31 - PubMed
  328. J Cell Biol. 2004 Dec 6;167(5):925-34 - PubMed
  329. Am J Physiol Endocrinol Metab. 2001 Sep;281(3):E489-99 - PubMed
  330. J Surg Oncol. 2008 Feb 1;97(2):146-9 - PubMed
  331. Cancer Treat Res. 2009;152:275-87 - PubMed
  332. Int J Cancer. 1999 Oct 22;84(5):489-93 - PubMed
  333. Cancer. 2006 Oct 1;107(7):1607-16 - PubMed
  334. Eur J Cardiothorac Surg. 1990;4(9):477-81 - PubMed
  335. J Musculoskelet Neuronal Interact. 2005 Oct-Dec;5(4):363-6 - PubMed
  336. Mayo Clin Proc. 2012 May;87(5):475-87 - PubMed
  337. J Clin Oncol. 1994 Dec;12(12):2699-705 - PubMed
  338. Cancer. 1990 Mar 15;65(6):1418-28 - PubMed
  339. Cancer Metastasis Rev. 2009 Jun;28(1-2):247-63 - PubMed
  340. Diagn Mol Pathol. 1996 Sep;5(3):214-9 - PubMed
  341. J Clin Oncol. 2005 Jan 20;23(3):559-68 - PubMed
  342. J Clin Oncol. 2002 Apr 15;20(8):2150-6 - PubMed
  343. J Drug Target. 1994;2(5):391-6 - PubMed

Publication Types

Grant support